Her brother and chairman of the African Integrated Development Enterprise Public Benefit Corporation, Chidi Achebe, made this known in a LinkedIn post on July 2.
Chidi stated that the hospital, a premier teaching hospital of Harvard Medical School based in Boston, Massachusetts, notified Maureen of her award in a letter dated July 2, 2024, which he also shared.
The post read, “2024 Faculty Development and Diversity Awards
“To God be the glory always! Ekenedili Chukwunna! Very big deal at Harvard! All glory to God!
“Maureen Okam-Achebe, President, AIDE Healthcare International, Associate Professor, Harvard Medical School, Director, Harvard University’s Brigham and Women’s Hospital Outpatient Infusion Centre. Also Clinical Director, Non-Malignant Hematology Clinic. Director, Brigham and Women’s Hospital Sickle Cell Programme and Instructor in Medicine, Harvard Medical School. Triple-board certified in Medical Oncology, Hematology, and Internal Medicine. Alumnus of the University of Port Harcourt Medical School and the M.T. Chan Harvard School of Public Health.
“Sweetie: Very proud of you. Keep on keeping on!”
Quick facts about Maureen Achebe
Maureen Achebe earned her first medical degree from the University of Port Harcourt, Nigeria; a Haematology and Medical Oncology training at Yale School of Medicine; and a Master’s in Public Health at Harvard’s T.H. Chan School of Public Health.
The doctor is also an Associate Professor at Harvard Medical School; Director of Brigham and Women’s Hospital Outpatient Infusion Center; clinical director, of the Non-Malignant Hematology Clinic; director, of Brigham and Women’s Hospital sickle cell program; and instructor in medicine, at Harvard Medical School
The medical expert co-chairs the data subcommittee of the American Society of Hematology Consortium on Newborn Screening for Sickle Cell Disease in Africa.
The sub-committee seeks to demonstrate the benefits of screening and early intervention for SCD underway in seven countries in sub-Saharan Africa.
She also serves as a commissioner on the Lancet Non-Communicable Disease and Injuries Nigeria Poverty Commission as the sickle cell disease expert and guides the identification and prioritisation of policies, interventions, and integrated delivery platforms to effectively address and reduce SCD burden in the country.
The expert is actively involved in clinical trials and translational research at BWH and was an investigator in the development of two of the most recently used US FDA-approved drugs for SCD.
According to Brigham and Women’s Hospital, Maureen Achebe will be honoured for her accomplishments on October 28, 2024.
